SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-043418
Filing Date
2024-04-10
Accepted
2024-04-10 16:59:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A crbp_defa_14a_2024_04_10.htm DEFA14A 41191
  Complete submission text file 0000950170-24-043418.txt   42294
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37348 | Film No.: 24836474
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)